Tsuyoshi Kadomatsu

12PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Agricultural molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 17, 2024
The Two Faces of Angiopoietin-Like Protein 2 in Cancer.

Haruki Horiguchi, Tsuyoshi Kadomatsu, Yuichi Oike

|Sep 25, 2024
Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy.

Shinsei Yumoto, Haruki Horiguchi, Tsuyoshi Kadomatsu

|Mar 12, 2024
Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.

Haruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita

|Nov 02, 2023
Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine.

Hirotaka Fukami, Jun Morinaga, Hironori Nakagami

|Sep 22, 2023
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis.

Haruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita

|Jul 15, 2023
ANGPTL2-mediated epigenetic repression of MHC-I in tumor cells accelerates tumor immune evasion.

Tsuyoshi Kadomatsu, Chiaki Hara, Ryoma Kurahashi

Pageof 2

Frequent Collaborators

8 joint publications

Haruki Horiguchi

8 joint publications

Yuichi Oike

5 joint publications

Michio Sato

4 joint publications

Toshiro Moroishi